Digital exercise program aims to boost recovery for breast cancer survivors

NCT ID NCT07676591

Not yet recruiting Disease control Sponsor: University of Valencia Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests a 12-week program called EmpowerHer that combines home-based exercise via a mobile app with weekly in-person group sessions. It aims to improve health-related quality of life, reduce fatigue, anxiety, and depression, and increase physical fitness in breast cancer survivors aged 35 to 65. Researchers compare the program to usual medical care across five European countries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EmpowerHer Hybrid Program (exercise and education via app and group sessions)
What this could lead to: If successful, this program could offer a practical, scalable way to improve quality of life, reduce fatigue, and boost fitness for breast cancer survivors.
What could go wrong: This is a relatively small trial (147 participants) testing a behavioral intervention, so results may not apply to all survivors. The program requires smartphone access and willingness to attend group sessions, which may limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CANCER SURVIVORS EXERCISE THERAPY MOBILE APPLICATIONS QUALITY OF LIFE SOCIAL SUPPORT

Contacts and locations

Locations

Department of Physiotherapy, Faculty of Physiotherapy, University of Valencia

Valencia, Valencia, 46010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.